Chargement en cours...
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
OBJECTIVE: Long-acting β(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are burdened by the potential risk of inducing cardiovascular serious adverse events (SAEs) in COPD patients. Since the risk of combining a LABA with a LAMA could be greater, we have carried out a quantitativ...
Enregistré dans:
| Publié dans: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5723113/ https://ncbi.nlm.nih.gov/pubmed/29255354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S146338 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|